MST– Medical Surgery Technologies Ltd. is a privately-held Israeli company which has developed AutoLap, an advanced image-based laparoscope positioning system for minimally invasive surgical procedures.
MST is commercializing AutoLap, an image-based laparoscope positioning system for the multi-billion dollar laparoscopic surgery market.
AutoLap takes the laparoscope out of the human hands of operating room assistants and nurses allowing the surgeon to seamlessly control the laparoscope’s movement.
Powered by proprietary image analysis software, AutoLap interacts with the surgeon’s movements and directions within the surgical cavity providing precise laparoscope movement and positioning and offering full and natural control and exceptional intraoperative image capabilities – all with minimal user interaction.
AutoLap is FDA cleared and CE Mark approved and is being used in the clinical setting. Additional system modules and versions are currently under regulatory review.
On June 30, 2015, MST
announced the closing of its Series C investment round. The $12.5 million investment was led by Haisco Pharmaceutical Group (“Haisco”), a leading Chinese pharmaceutical manufacturer, and was joined by existing MST investors: Triventures, SCP Vitalife Partners, Agate MaC Medical Investments, OurCrowd and Jacobs Investment Company.